News

Basal cell carcinoma's low immunogenicity linked to suppression of antigen presentation from its cell of origin
Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...
The American Journal of Managed Care4d
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was ...
E! Online2d
Sarah Ferguson Says Double Cancer Diagnosis Felt “Like a Death Sentence”
The Up All Night star was declared "100-percent clear" of breast cancer after treatment and a double mastectomy. The Dexter ...
News Medical18d
New 3D imaging technique enhances basal cell carcinoma diagnosis
that could significantly improve the diagnosis and treatment of basal cell carcinoma (BCC), the most common form of skin cancer worldwide. This advanced technique uses photoacoustic imaging (PAI ...
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90).The Company to Expand the Study into Additional Trial Sites in EuropePhiladelphia, ...
Rolling Out10d
5 types of skin cancer and how fast they actually grow
Discover the growth rates of 5 different skin cancers, from slow-developing basal cell carcinomas to aggressive melanomas, ...
Medindia23d
Senhwa Biosciences Announces Positive Clinical Data from Phase 1/Expansion Trial of Silmitasertib (CX-4945) in the Treatment of Basal Cell Carcinoma
Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that the completion ...